Ads
related to: provigil dosing information for dogs instructions book 2 full
Search results
Results From The WOW.Com Content Network
It contains concise, thorough information on the diagnosis and treatment of disease in a wide variety of species. [2] The Manual is available as a book, published on a non-profit basis. [3] Additionally, the full text can be accessed for free via the website, or downloaded in its entirety via an app. [4]
Modafinil, sold under the brand name Provigil among others, is a central nervous system (CNS) stimulant and eugeroic (wakefulness promoter) medication used primarily to treat narcolepsy, [3] [8] [15] a sleep disorder characterized by excessive daytime sleepiness and sudden sleep attacks. [16]
[3] [2] [4] The modafinil analogues are of interest in the potential treatment of a condition involving the misuse of stimulant drugs (psychostimulant use disorder or PSUD), as drugs that help increase motivation (pro-motivational agents) to treat motivational disorders, [4] [5] [6] and for treatment of neurodegenerative diseases such as ...
Armodafinil exhibits linear time-independent kinetics following single and multiple oral dose administration. Increase in systemic exposure is proportional over the dose range of 50–400 mg. No time-dependent change in kinetics was observed through 12 weeks of dosing. Apparent steady state for armodafinil was reached within 7 days of dosing.
For the first time in a decade, rates of adult obesity in the United States have dropped, a new study has found.. The study followed nearly 17 million people, the majority of whom were in the 26 ...
Dog Owners' Ideas and Strategies Regarding Dental Health in Their Dogs-Thematic Analysis of Free Text Survey Responses. Front Vet Sci. 2022 May 3;9:878162. doi: 10.3389/fvets.2022.878162. PMID ...
The bird flu outbreak has taken concerning turns, with more than 60 human cases confirmed. Experts outlined four signs that the virus is going in the wrong direction.
The pharmaceutical company Cephalon, the original United States market rights holder of modafinil, has demonstrated initiative in the development of a successor to the prototypical eugeroic. [25]